Table 1.
Study | In silico approach | Major outcome | Reference |
---|---|---|---|
Structure-based screening of a lead-like subset of NP from ZINC | Cascade docking followed by a consensus approach | One computational had reported activity. Additional natural products were identified for screening. | Medina-Franco et al., 2011 |
Ligand- and structure-based screening of 800 NP | QSAR model based on linear discriminant analysis and consensus docking. | Six consensus hits were identified as potential inhibitors. | Maldonado-Rojas et al., 2015 |
Structure-based screening of 111,121 molecules. | Docking-based screening of synthetic screening compounds. | Identification of a low micromolar hit with a novel scaffold. Further similarity searching led to the identification of two more potent hits. | Chen et al., 2014 |
Ligand-based screening of 500 compounds. | Pharmacophore-based virtual screening. | Identification of one inhibitor of DNMT1 with activity in the low micromolar range. The hit showed some selectivity vs. DNMT3B. | Hassanzadeh et al., 2017 |
Structure- and ligand-based screening of 53,000 synthetic compounds. | Pharmacophore model, a Naïve Bayesian classification model, and ensemble docking. | Two compounds showed DNMT1 inhibitory activity at single but low concentration of 1 μM. | Krishna et al., 2017 |
NP: natural products.